Key result
GRK2 hemizygosity partially protects mice against Angiotensin II-induced hypertension and vascular remodeling.
Why the study?
Does genetic reduction of GRK2 protect against Angiotensin II-induced hypertension and vascular remodeling in mice?
Population
Adult GRK2 hemizygous mice (GRK2(+/-)) and wild-type (WT) littermates
Comparison
Genetic reduction of GRK2 with Angiotensin II… vs Wild-type littermates with Angiotensin II infusion
Design
Preclinical
Authors
Loading...
GRK2 reduction may enhance vasodilation; leaves open whether selective inhibitors will benefit human hypertension.
Does genetic reduction of GRK2 protect against Angiotensin II-induced hypertension and vascular remodeling in mice?
Genetic reduction of GRK2 protects against Angiotensin II-induced hypertension and vascular remodeling in mice by preserving nitric oxide bioavailability, suggesting GRK2 inhibition as a potential therapeutic target.
Avendaño et al. (2013) studied Angiotensin II-induced hypertension. GRK2 hemizygosity (GRK2+/-) vs. Wild-type (WT) littermates was evaluated on Hypertension, vascular remodeling, and mechanical alterations after AngII infusion. GRK2 hemizygous mice were partially protected against Angiotensin II-induced hypertension, vascular remodeling, and endothelial dysfunction compared with wild-type littermates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: